In cases where back pain is not the direct result of an injury, it is usually caused by inflammation
Peptide therapy is delivered via subcutaneous injection, into the fatty tissue layer between the skin and muscle, to target these messenger cells and send signals to the body to stimulate specific processes such as tissue repair, weight loss and muscle recovery
(2003, bulletin of experimental biology
However, data supporting the use of BPC 157 for described musculoskeletal benefits are limited to rat and in vitro studies
Common side effects of BPC-157 arent usually serious and may include: Mild injection site reactions (itching, redness, swelling, pain, etc.) Headaches Dizziness Nausea In rare cases, patients may experience fevers, blistering at the injection site, muscle aches, rashes, vomiting, hives, or other signs of an allergic reaction
Source: Synthesized via solid-phase peptide synthesis